Men with prostate cancer that returns after surgery or radiation and are left with few options could benefit from a new ...

Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in ...

A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 ...

The U.S. Food and Drug Administration has approved a new treatment for advanced breast cancer. Drugmaker Eli Lilly announced on Sept. 25 the approval of Inluriyo, an oral estrogen receptor antagonist, ...

Intraoperative radiation therapy (IORT) costs breast cancer patients less time and money, but access is limited in the United ...

A gene therapy from Regeneron, a pancreatic cancer medicine from Revolution Medicines and a porphyria drug from Disc Medicine ...

Shares of Revolution Medicines gained after the Food and Drug Administration granted a priority voucher to speed up the development and review of the company's cancer treatment. The stock rose 8.9% to ...

The Food and Drug Administration is announcing the first round of drugs that will receive drastically expedited reviews at ...

Because they don’t actually contain tobacco, nicotine pouches may be viewed as safer than smoking cigarettes, using smokeless ...

Hamlin was given the treatment as part of a clinical trial after receiving a diagnosis of melanoma last year. She recently ...

NG-350A has received FDA fast track designation for mismatch repair-proficient locally advanced rectal cancer, addressing a ...